Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

EmbraceRX vs JRNYS

EmbraceRX
Graded #362

Lower grade

vs+13.100000000000001
JRNYS
Graded #88

Higher grade

The verdict

JRNYS takes it — 71.7/100 to 58.6/100.

JRNYS grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. JRNYS is a telehealth weight-loss program built around branded GLP-1 medications, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), dulaglutide, and liraglutide (Saxenda), paired…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueJRNYS +33
45
78
Dose & formulationJRNYS +14
56
70
Clinical oversightJRNYS +8
76
84
Labs & monitoringJRNYS +9
52
61
FulfillmentEmbraceRX +8
73
65
Contract termsEven
55
55
EmbraceRX · left barJRNYS · right bar

The numbers

MetricEmbraceRXJRNYS
WeighScore58.6/10071.7/100
GradeCC
Scorecard rank#362#88
SemaglutideNot disclosed$89/mo (plus a separate fee, brand-name)
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
EmbraceRX

Graded #362 · C

Strengths

  • Broad compounded GLP-1 menu — semaglutide (+B12), tirzepatide, oral semaglutide/tirzepatide capsules, plus Lipo-B
  • Large peptide/longevity catalog (BPC-157, GHK-Cu, NAD+, MOTS-C) across injectable, oral, topical, and nasal formats
  • Clinician-guided, compounded at FDA-registered pharmacies; partners with a licensed physician network (Samaritan MD)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, CCPA, Returns & Refunds)

Where it loses points

  • Pricing not shown upfront — revealed only at checkout after a dose selection
  • Offers investigational/research compounds (e.g., retatrutide, AOD-9604) that are not FDA-approved
  • Compounding pharmacy partner not named ('FDA-registered pharmacies')
  • Not LegitScript-certified (no certification displayed)
JRNYS

Graded #88 · C

Strengths

  • Branded GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda)
  • Insured members may pay ~$25/mo for medication after deductible
  • Includes 1-on-1 coaching at every membership tier
  • Led by CMO Dr. Henry Legere with strong academic credentials
  • Transparent membership pricing ($89-$169/mo)

Where it loses points

  • Medication cost separate from membership; self-pay varies
  • Best value requires commercial insurance coverage
  • Compounded option not disclosed; brand-focused
  • State availability not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard